Advertise | About Us | Contact Us

Expert Talk

The Emergence of 3D Printing in Expanding Clinical Research and Pharmaceutical Compounding

The emergence of D printing provides two distinct benefits in this area First researchers and formulators

The intent is no longer the challenge Most Pharma organisations are clear they want faster more confident

AI technologies are influencing nearly every stage of the drug development lifecycle from early discovery to postmarket monitoring

Bioprocessing has undergone a remarkable shift in recent years driven by technologies that enable faster smarter

Inflammation is now recognised as a core biological process that when dysregulated contributes to a wide spectrum of chronic

After speaking to more than industry leaders I believe at the core of it is a reliance on decontextualised historical data

Over the next decade pharmacovigilance will evolve from a compliancedriven reactive function into a proactive safety

Over the past two decades the most transformative milestones in bioanalytical automation have redefined how quality

Since its introduction by the FDA in PAT has shifted quality assurance from endproduct testing to realtime

I think the convergence of AI and machine learning with pharma marketing is going well beyond building brands